Clinical Study Links LCLT Supplementation to Increased Endurance and Faster Recovery In this study, a randomized double-blind, placebo-controlled trial, eighty participants, men and women 21- to 65-years-old, were split into two groups of forty participants each, a placebo group and a L-Carnitine L-Tartrate group
For additional health benefits The buzz around GLP-1 drugs isn't just about weight loss and diabetes anymore
This study reveals a much larger issue: how incentive structures in our healthcare system often prevent patients from receiving the best careespecially when that care is simple, effective, and inexpensive
Many of the mechanisms have been elucidated by the Jaeschke group in Kansas [18,36,37]
The approval for manufacturing and marketing the drug for both type 2 diabetes and obesity indications was granted earlier by the Drugs Controller General of India (DCGI)